James G. Marken - Jun 7, 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP OPS & PROD DEV
Signature
/s/ James G. Marken, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Jun 7, 2024
Transactions value $
-$750,590
Form type
4
Date filed
6/11/2024, 04:51 PM
Previous filing
Apr 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Options Exercise $359K +7.25K +6.23% $49.51 124K Jun 7, 2024 Direct F1
transaction ANIP Common Stock Options Exercise $302K +5.3K +4.29% $57.06 129K Jun 7, 2024 Direct
transaction ANIP Common Stock Tax liability -$751K -11.1K -8.6% $67.70 118K Jun 7, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise -$359K -7.25K -100% $49.51 0 Jun 7, 2024 Common Stock 7.25K $49.51 Direct F3
transaction ANIP Stock Option (right to buy) Options Exercise -$302K -5.3K -100% $57.06 0 Jun 7, 2024 Common Stock 5.3K $57.06 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares.
F2 The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price.
F3 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.
F4 25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022.